The quest for well-being: A qualitative study of the experience of taking antipsychotic medication

Psychology and Psychotherapy: Theory, Research and Practice

Volumn 77, Issue 1, 2004, Pages 19-33

  Carrick, Rachael ^a   Mitchell, Annie ^a   Powell, Richard A ^a   Lloyd, Keith ^b  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONSTIPATION; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DATA ANALYSIS; DOCTOR PATIENT RELATION; DRUG CHOICE; DRY EYE; EXPERIENCE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PSYCHOSIS; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RIGIDITY; SCHIZOPHRENIA; SIDE EFFECT; TREMOR; WELLBEING;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; GREAT BRITAIN; HEALTH STATUS; HOLISTIC HEALTH; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PSYCHOTIC DISORDERS; SELF ADMINISTRATION;

EID: 1642377184     PISSN: 14760835     EISSN: None     Source Type: Journal    
DOI: 10.1348/147608304322874236     Document Type: Article

References (44)

1. Awad, A. G., Voruganti, L. N. P., Heslegrave, R. J., & Hogan, T. P. (1996). Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome. International Clinical Psychopharmacology, 11 (Suppl. 2), 55-59.
2. Barnes, T. R. E., & McPhillips, M. A. (1995). How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia. International Clinical Psychopharmacology, 10(Suppl. 3), 115-121.
3. Barry, C. A., Bradley, C. P., Britten, N., Stevenson, F. A., & Barber, N. (2000). Patients' unvoiced agendas in general practice consultations: Qualitative study. British Medical Journal, 320(7244), 1246-1250.
4. Bhavnani, S. M., & Levin, G. M. (1996). Antipsychotic agents: A survey of the prevalence, severity and burden of side effects. International Clinical Psychopharmacology, 11(1), 1-12.
5. Brenner, M., Brown, J., & Canter, D. (1985). The Research Interview. London: Academic Press.
6. Britten, N., Stevenson, F. A., Barry, C. A., Barber, N., & Bradley, C. P. (2000). Misunderstandings in prescribing decisions in general practice: Qualitative study. British Medical Journal, 320(7233), 484-488.
7. Brown, S. (1997). Excess mortality of schizophrenia: A meta-analysis. British Journal of Psychiatry, 171, 502-508.
8. Bulmer, M. (1984). Sociological research methods: An introduction. London: MacMillan.
9. Bunn, M. H., O'Connor, A. M., Tansey, M. S., Jones, B. D. W., & Stinson, L. E. (1997). Characteristics of clients with schizophrenia who express certainty or uncertainty about continuing treatment with depot neuroleptic medication. Archives of Psychiatric Nursing, 11, 238-248.
10. Casey, D. E. (1995). Motor and mental aspects of extrapyramidal syndromes. International Clinical Psychopharmacology, 10(Suppl. 3), 105-114.
11. Casey, D. E. (1996). Side effect profiles of new antipsychotic agents. Journal of Clinical Psychiatry, 57(Suppl. 11), 40-45.
12. Casey, D. E. (1997). The relationship of pharmacology to side effects. Journal of Clinical Psychiatry, 58(Suppl. 10), 55-62.
13. Charmaz, K. (1983). The grounded theory method: An explication and introduction. In R. Emerson (Ed.), Contemporary field research (pp. 109-126). Boston: Brown.
14. Corbin, J., & Strauss, A. L. (1990). Grounded theory and research: Procedures, canons and evaluative criteria. Qualitative Sociology, 13, 3-21.
15. Davidhizar, R. E. (1985). Can clients with schizophrenia describe feelings and beliefs about taking medication? Journal of Advanced Nursing, 10, 469-473.
16. Department of Health (1998). Our healthier nation: A contract for health. London: Department of Health.
17. Finn, S. E., Bailey, J. M., Schultz, R. T., & Faber, R. (1990). Subjective utility ratings of neuroleptics in treating schizophrenia. Psychological Medicine, 20, 843-848.
18. Franz, M., Lis, S., Pluddemann, K., & Gallhofer, B. (1997). Conventional versus atypical neuroleptics: Subjective quality of life in schizophrenic patients [see comments]. British Journal of Psychiatry, 170, 422-5, 422-425.
19. Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies in qualitative research. Chicago: Aldine.
20. Green, J., & Britten, N. (1998). Qualitative research and evidence based medicine. British Medical Journal, 316, 1230-1232.
21. Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics - reliability and discriminative validity. Psychological Medicine, 13, 177-183.
22. Keks, N. A. (1996). Minimizing the non-extrapyramidal side-effects of antipsychotics. Acta Psychiatrica Scandinavica, 94, 18-24.
23. Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998). Randomised controlled trial of compliance therapy: 18 month follow-up. British Journal of Psychiatry, 172, 413-419.
24. Kerwin, R. W. (1994). The new atypical antipsychotics - a lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry, 164, 141-148.
25. Krueger, R. A. (1998). Moderating focus groups. London: Sage.
26. Larsen, E. B., & Gerlach, J. (1996). Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenia out-patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica, 93, 381-388.
27. Miller, R. (1997). Dose-response relationships for the antipsychotic effects and Parkinsonian side-effects of typical neuroleptic drugs: Practical and theoretical implications. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 21, 1059-1094.
28. Morgan, D. L. (1988). Focus groups as qualitative research. London: Sage.
29. Mortimer, A. (1998). Atypical antipsychotic drugs and their place in therapy. Progress in Neurology and Psychiatry, 2, 41-45.
30. Naber, D. (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psychopharmacology, 10(Suppl. 3), 133-138.
31. Oppenheim, A. N. (1992). Questionnaire design, interviewing and attitude measurement. London: Pinter.
32. Orely, J., Saxena, S., & Herrman, H. (1998). Quality of life and mental illness: Reflections from the perspective of WHOQOL. British Journal of Psychiatry, 172, 291-293.
33. Rennie, D. L., Phillips, J. R., & Quartaro, G. K. (1988). Grounded theory: A promising approach to conceptualization in psychology? Canadian Psychology, 29(2), 139-150.
34. Rogers, A., Day, J. C., Williams, B., Randall, F., Wood, P., Healy, D., & Bentall, R. P. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Social Science and Medicine, 47, 1313-1323.
35. Rogers, A., & Pilgrim, D. (1993). Service users' views of psychiatric treatments. Sociology of Health & Illness, 15, 612-631.
36. Spikler, B. (1990). Introduction. In B. Spikler (Ed.), Quality of life assessments in clinical trials (pp. 1-9). New York: Raven.
37. Spradley, J. P. (1979). The ethnographic interview. Orlando: Holt, Rinehart & Winston.
38. Stiles, W. B. (1993). Quality control in qualitative research. Clinical Psychology Review, 13, 593-618.
39. Strauss, A. L., & Corbin, J. (1990). Selective coding. In Anonymous, Basics of qualitative research: Grounded theory procedures and techniques (pp. 116-142). Newbury Park, CA: Sage.
40. Streufert, S., & Gengo, F. M. (1993). Drugs and behaviour: An introduction. In S. Streufert & F. M. Gengo (Eds.), Effects of drugs on human fuctioning. New York: S. Karger.
41. Turner, B. A. (1981). Some practical aspects of qualitative data analysis: One way of organising the cognitive processes associated with the generation of grounded theory. Quality and Quantity, 15, 225-247.
42. Van Putten, T. (1974). Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry, 31, 67-72.
43. Van Putten, T., May, P. R., Marder, S. R., & Wittmann, L. A. (1981). Subjective response to antipsychotic drugs. Archives of General Psychiatry, 38(2), 187-190.
44. Voruganti, L. N., Heslegrave, R. J., & Awad, A. G. (1997). Quality of life measurement during antipsychotic drug therapy of schizophrenia. Journal of Psychiatry and Neuroscience, 22(4), 267-274.